Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Proteins and peptides (PPs) have gradually become more attractive therapeutic molecules than small molecular drugs due to their high selectivity and efficacy, but fewer side effects. Owing to the poor stability and limited permeability through gastrointestinal (GI) tract and epithelia, the therapeut...
Main Authors: | Quangang Zhu, Zhongjian Chen, Pijush Kumar Paul, Yi Lu, Wei Wu, Jianping Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383521001167 |
Similar Items
-
An Update on Pharmaceutical Strategies for Oral Delivery of Therapeutic Peptides and Proteins in Adults and Pediatrics
by: Nirnoy Dan, et al.
Published: (2020-12-01) -
In Vitro, Ex Vivo and In Vivo Evaluation of Microcontainers for Oral Delivery of Insulin
by: Jacob Rune Jørgensen, et al.
Published: (2020-01-01) -
Transmucosal Absorption Enhancers in the Drug Delivery Field
by: Sam Maher, et al.
Published: (2019-07-01) -
Have existing pharmaceutical excipients failed to enable oral/nasal protein delivery?
by: Shireesh Apte
Published: (2017-03-01) -
Oral Delivery of Biologics via the Intestine
by: Roger New
Published: (2021-12-01)